Cover: Understanding the Demographics of the Opioid Overdose Death Crisis

Understanding the Demographics of the Opioid Overdose Death Crisis

Published Nov 1, 2021

by David Powell

Download eBook for Free

FormatFile SizeNotes
PDF file 0.8 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

The United States is enduring the worst drug overdose crisis in its history. Relative to previous overdose epidemics, the opioid crisis is marked by its severity, breadth, and demographics. Some demographic groups have experienced staggering rates of over-dose growth. I examine overdose trends during the opioid crisis relative to historical disparities and evaluate the role of OxyContin's launch in explaining these trends. I use geographic variation in OxyContin's launch to understand the impacts of a large opioid shock on the demographics of the crisis. I find that OxyContin's introduction induced substantial and enduring differences in overdose rates across demographic groups.

Research conducted by

This research was funded by NDA and CDC and conducted by RAND Education and Labor.

This report is part of the RAND working paper series. RAND working papers are intended to share researchers' latest findings and to solicit informal peer review. They have been approved for circulation by RAND but may not have been formally edited or peer reviewed.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.